Press releases and news

Press release: Uppsala, 25 November 2021. In accordance with the resolution at the Annual General Meeting of Senzime AB (publ) on May 11, 2021, the three largest shareholders on 1 September 2021 have appointed a Nomination Committee for the 2022 Annual...
2021-11-12 08:45 Interim report January - September 2021 Regulatory Interim
Press release: Uppsala, November 12, 2021. Senzime AB’s (publ) Interim Report for January-September 2021 is now available on the company’s website www.senzime.com. Financial information for July - September 2021 Financial information for January...
NEWS: Uppsala October 15, 2021. Senzime is proud to announce that the TetraGraph system received great focus during the American Society of Anesthesiology’s Annual meeting in San Diego October 8-12, as presented in the highlights below. A study...
Press release: Uppsala 4th of October 2021. At today’s Capital Market Day, Senzime provides a business update regarding ongoing businesses, evaluations, and key figures. Senzime markets CE and FDA approved systems and cloud-based software to digitally...
NEWS: Uppsala September 17, 2021. In the October 2021 edition of Anesthesiology, the Official Journal of the American Society of Anesthesiology, a comparative study of the Senzime TetraGraph EMG monitor and the previous gold-standard TOF-Watch AMG monitor...
NEWS: Uppsala September 13 2021. Recently published studies with an EMG monitor shows that the purchase can result in a robust cost benefit despite the expense associated with the technology, by reducing the risk of postoperative residual neuromuscular...
2021-08-27 08:45 Interim report January – June 2021 Regulatory Interim
Press release: Uppsala, August 27, 2021. Senzime AB’s (publ) Interim Report for January-June 2021 is now available on the company’s website www.senzime.com. Financial information for April - June 2021 Financial information for January - June...
Uppsala, 30 June 2021. Senzime AB (publ) announces that the company’s shares are admitted for trading on Nasdaq Stockholm's main market today. “It’s fantastic milestone for Senzime to be listed on Nasdaq Stockholm's main market. Senzime...
Uppsala, 24 June 2021. On 23 June 2021, Senzime AB (publ) announced that Nasdaq Stockholm’s Listing Committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market, conditioned upon customary...
Uppsala, 23 June 2021. Senzime AB (publ) announces that Nasdaq Stockholm's Listing Committee has approved the company’s application for admission of trading of the company’s shares on Nasdaq Stockholm’s main market. The approval is conditioned...